The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults

被引:0
|
作者
Petersen, E [1 ]
机构
[1] Statens Serum Inst, Dept Gastrointestinal & Parasit Dis, World Hlth Org, Natl Malaria Diagnost Ref Ctr, DK-2300 Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Data on the long-term safety of atovaquone/proguanil in nonimmune travelers are limited. Methods: An open-label study, involving 300 Danish soldiers stationed in Eritrea for 6 months was initiated. The subjects self-reported their symptoms on a post-travel questionnaire. The study compared the symptoms of compliers and noncompliers. Results: No serious adverse events occurred. Diarrhea, stomach pain, headache, cough, and loss of appetite were the most common symptoms reported. No case of Plasmodium falciparum malaria occurred. Conclusions: Atovaquone/proguanil was safe and well tolerated in this group of long-term nonimmune travelers.
引用
收藏
页码:S13 / S15
页数:3
相关论文
共 50 条
  • [41] Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers:: a randomised, double-blind study
    Hogh, B
    Clarke, PD
    Camus, D
    Nothdurft, HD
    Overbosch, D
    Günther, M
    Joubert, I
    Kain, KC
    Shaw, D
    Roskell, NS
    Chulay, JD
    [J]. LANCET, 2000, 356 (9245): : 1888 - 1894
  • [42] Imported malaria management in France -: Experience report of uncomplicated falciparum malaria treatment in adults with oral atovaquone-proguanil
    Vatan, R
    Pistone, T
    Millet, P
    Etienne, G
    Mercié, P
    Longy-Boursier, M
    Malvy, D
    [J]. PRESSE MEDICALE, 2006, 35 (04): : 571 - 577
  • [43] Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines
    Faucher, JF
    Binder, R
    Missinou, MA
    Matsiegui, PB
    Gruss, H
    Neubauer, R
    Lell, B
    Que, JU
    Miller, GB
    Kremsner, PG
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) : 1147 - 1154
  • [45] PROLONGED MALARIA PROPHYLAXIS WITH CHLOROQUINE AND PROGUANIL (CHLOROGUANIDE) IN A NONIMMUNE RESIDENT POPULATION OF AN ENDEMIC AREA WITH A HIGH PREVALENCE OF CHLOROQUINE RESISTANCE
    GOZAL, D
    HENGY, C
    FADAT, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) : 373 - 376
  • [46] Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review
    Savelkoel, Jelmer
    Binnendijk, Klaas Hendrik
    Spijker, Rene
    van Vugt, Michele
    Tan, Kathrine
    Hanscheid, Thomas
    Schlagenhauf, Patricia
    Grobusch, Martin Peter
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2018, 21 : 3 - 20
  • [47] A systematic review and meta-analysis of the effectiveness and safety of atovaquone-proguanil (Malarone) for chemoprophylaxis against malaria
    Nakato, Halima
    Vivancos, Roberto
    Hunter, Paul R.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) : 929 - 936
  • [48] Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: The second report from the research group
    Kimura, Mikio
    Koga, Michiko
    Kikuchi, Tadashi
    Miura, Toshiyuki
    Maruyama, Haruhiko
    [J]. PARASITOLOGY INTERNATIONAL, 2012, 61 (03) : 466 - 469
  • [49] Long-term safety and effectiveness of lamictal in adults
    Risner, ME
    Groenke, DA
    Messenheimer, JA
    [J]. EPILEPSIA, 1999, 40 : 140 - 140